Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
The Pathophysiologic Basis of Managing Chronic Atherosclerotic Cardiovascular DiseaseDiagnosing Coronary Artery Disease in the Patient Presenting with Stable Ischemic Heart Disease: The Role of Anatomic versus Functional Testing
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids
Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy
A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Exercise and Cardiac Rehabilitation
When to Consider Coronary Revascularization for Stable Coronary Artery Disease
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy
Ischemic Heart Disease in Women
Chronic Coronary Disease in Older Adults
Racial and Ethnic Disparities in the Management of Chronic Coronary Disease